NIFTY  9,595.10  0.90%
  SENSEX  31,028.20  0.90%
 CURRENCY  Rs  64.45/$ 72.07/€, 82.52/£
  GOLD  28,884.00  0.78%
  SILVER  40,130.00  0.82%
  DAX  12,602.20  -0.15%
  FTSE  7,547.63  0.40%
  CAC  5,336.64  -0.01%
  HANG SENG  25,639.30  0.03%
  NIKKEI  19,686.80  -0.64%
  Shanghai Composite  3,110.06  0.04%
  DOW JONES  21,080.30  -0.01%
  NASDAQ  6,210.19  0.08%
  S&P 500  2,415.82  0.03%
INDIAN HOTELS - MD & CEO Rakesh Sharma Resigns Due To Personal Reasons Effective Sept 30 EARNINGS REPORT - Divi's Labs To Pay Dividend Of Rs 10/Share

Analysts Bullish On Sun Pharma

Video:

Play this video

October 10: Sun Pharma's stock is up 50% in the last six months and almost 75% in the last year. With the second-quarter earnings season around the corner, analysts have pegged very high ranges for the company’s revenue and profit growth. Watch this segment to know why Sun Pharma has seen the growth it has and why analysts think it is a promising pick.